Comment on "analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue" [Epstein JB et al., Oral Oncol 2008;44(6):538-44].

@article{Slater2009CommentO,
  title={Comment on "analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue" [Epstein JB et al., Oral Oncol 2008;44(6):538-44].},
  author={Lee J Slater},
  journal={Oral oncology},
  year={2009},
  volume={45 3},
  pages={296; author reply 297-8}
}
Epstein and associates recently evaluated the efficacy of chemiluminescence followed by toluidine blue staining (ViziLite Plus , Zila Pharmaceuticals, Phoenix, Arizona) in identifying oral potentially malignant lesions. They divided lesions into two groups: ‘‘serious pathology’’ (severe dysplasia, carcinoma in situ and squamous cell carcinoma) and presumably ‘‘non-serious pathology’’ (benign lesions, mild and moderate dysplasia). ViziLite Plus identified all ‘‘serious pathology’’ with no false… CONTINUE READING
2 Extracted Citations
4 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-4 of 4 references

Keratinizing dysplasia of the upper aerodigestive tract

  • BM Wenig
  • Pathol Case Rev 2008;13(1):9–16
  • 2008
1 Excerpt

Keratosis with and without atypia and carcinoma in situ

  • L. Barnes
  • 2nd ed. Revised and expanded. New York: Marcel…
  • 2001
1 Excerpt

Similar Papers

Loading similar papers…